Skip to content

Total Equity at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$435.19M-5.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$12.67B+2.2%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$5.35M+93.8%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$178.94M+7.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's total equity?
OrthoPediatrics (KIDS) reported total equity of $338.71M in Q1 2026.
How has OrthoPediatrics's total equity changed year-over-year?
OrthoPediatrics's total equity decreased by 2.4% year-over-year, from $347.15M to $338.71M.
What is the long-term trend for OrthoPediatrics's total equity?
Over 5 years (2020 to 2025), OrthoPediatrics's total equity has grown at a 8.1% compound annual growth rate (CAGR), from $234.77M to $346.6M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.